Zobrazeno 1 - 10
of 896
pro vyhledávání: '"Urate-lowering therapy"'
Publikováno v:
Consilium Medicum, Vol 26, Iss 10, Pp 679-683 (2024)
Aim. To evaluate treatment adherence among patients with gout. Materials and methods. One hundred and thirty-eight patients with gout were examined in the Dzhanelidze Saint Petersburg Research Institute of Emergency Care; 89.9% of them are men and
Externí odkaz:
https://doaj.org/article/7a563b1f60f147a497d932c5be0d0552
Publikováno v:
BMC Oral Health, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Objectives To explore the association between hyperuricemia and having periodontitis. Materials and methods A representative cross-sectional dataset of 10,158 adults was extracted from the National Health and Nutrition Examination Survey (NH
Externí odkaz:
https://doaj.org/article/7b5708983ff44272b75886b91337d154
Autor:
Alexia Steelandt, Ambre Hittinger, Lukshe Kanagaratnam, Isabelle Kazes, Pierre Clavel, Loïs Bolko, Philippe Rieu, Jean-Hugues Salmon
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Uncontrolled gout can cause articular impairment but is also associated with a global and cardiovascular excess mortality, especially in dialysis population. Data documented within existing research is not conclusive regarding gou
Externí odkaz:
https://doaj.org/article/0bdffa9c05014690a12730df23eb71d3
Autor:
Sun W, Zhao X, Dalbeth N, Terkeltaub R, Cui L, Liu Z, Han L, Wang C, Zhang H, Bao Y, Li C, Lu J
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 2657-2668 (2024)
Wenyan Sun,1,* Xuetong Zhao,2– 4,* Nicola Dalbeth,5,* Robert Terkeltaub,6 Lingling Cui,1 Zhen Liu,1 Lin Han,1 Can Wang,1 Hui Zhang,1,7 Yiming Bao,2– 4 Changgui Li,1,7 Jie Lu1,7 1Shandong Provincial Key Laboratory of Metabolic Diseases
Externí odkaz:
https://doaj.org/article/498b4987d0e1475e812c3792128f8147
Autor:
Fares Saliba, Omar Mourad, Jonathan Mina, Fadi Haddadin, Laurence Aoun, Shaza Almardini, Saif Abu-baker, Koushik Sangaraju, Gaetano Di Pietro, Daniel Gaballa, Suzanne El-sayegh
Publikováno v:
Rheumato, Vol 4, Iss 1, Pp 49-62 (2024)
Gout is highly prevalent in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), owing to impaired uric acid excretion. However, treating gout in this population is challenging due to concerns about medication safety and eff
Externí odkaz:
https://doaj.org/article/ee4a6d2e85884f47b56864d61de406a0
Publikováno v:
BMC Primary Care, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Gout is the most common inflammatory arthritis and is almost exclusively managed in primary care, however the course and severity of the condition is variable and poorly characterised. This research aims improve understanding abou
Externí odkaz:
https://doaj.org/article/d589385630a54feca2a604e3d955853c
Autor:
M. S. Eliseev, O. V. Zhelyabina
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 73-78 (2023)
Objective: to analyze the association between medications intake and the development of type 2 diabetes mellitus (T2DM) in patients with gout. Material and methods. The study included 444 patients with gout without T2DM. The median follow-up time was
Externí odkaz:
https://doaj.org/article/391d98dabd604816a3feaf577ca8e395
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1277-1295 (2023)
Abstract Introduction This drug utilization study evaluated the impact of 2019 label changes on real-world febuxostat utilization among patients with gout. We describe the numbers and proportions of patients initiating febuxostat as new users (allopu
Externí odkaz:
https://doaj.org/article/26cde3795b6e4a468ae46eaea148c29e
Autor:
O. M. Drapkina, V. I. Mazurov, A. I. Martynov, E. L. Nasonov, S. A. Saiganov, A. M. Lila, R. A. Bashkinov, I. N. Bobkova, Ch. T. Baimukhamedov, I. Z. Gaidukova, N. I. Guseinov, D. V. Duplyakov, M. S. Eliseev, A. T. Mamasaidov, N. A. Martusevich, Kh. T. Mirakhmedova, I. T. Murkamilov, D. A. Nabieva, V. A. Nevzorova, O. D. Ostroumova, V. V. Salukhov, G. A. Togizbaev, E. A. Trofimov, Yu. Sh. Khalimov, A. I. Chesnikova, S. S. Yakushin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/8333abec51d443a08bc1a273f09da42c
Autor:
Iris Rose Peeters, Alfons A. den Broeder, William J Taylor, Nathan den Broeder, Marcel Flendrie, Noortje van Herwaarden
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-16 (2023)
Abstract Background Long-term gout treatment is based on reducing serum urate levels using urate-lowering therapy (ULT). Most guidelines recommend using a lifelong continuation treat-to-target (T2T) strategy, in which ULT is dosed or combined until a
Externí odkaz:
https://doaj.org/article/5f9b64ad6e8340238360ec1fcc8063b3